| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Managing Teams and Creating Innovation - All for One and One for All |
|
E-Folder - Managing Teams and Creating Innovation - All for One and One for All
Jorma Ollila has spoken in an interview of the caring atmosphere which
distinguished Nokia, the mobile phone giant, from other companies he has
worked for. When one person felt tired or sick the others would According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rally
round and cover for that person by cancelling meetings, rearranging
schedules and so on. In my previous article, "Successful Leaders versus Failed Leaders" I also promised to talk about the differen ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ces between managers and leaders, and
it behoves me to make the distinction clear before proceeding any
further. Abraham Zaleznik in his article for the Harvard Business Review,
"Managers and Leaders: Are lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. they Different?"says that leaders and managers
differ in respect of their personal history, motivation and personality. He has
talked about managers as people who feel content with the status quo and
arg here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ues that managers tend to get on well in hierarchical cultures. Managers
get their targets and goals more from outside and their relation to them is
therefore more objective Leaders, on the other hand, a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e innovators. They have faced during their life
history the kind of experiences that make them yearn for change. They are
more intuitive, and try bring about changes in order to achieve their visions. The ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc crunch comes, however, when leaders by leading from the front have
to lay down their own lives, and the lives of others - a whole lot easier to do -
in the single minded pursuit of these visions. Successf easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ul wartime leaders often
make failed peacetime leaders and vice versa. By analogy companies where
things are going well require a different sort of leadership from companies
that are struggling for their nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically existence. However managers need to motivate their teams too and it is a sine qua non that you manage people as well as processes, and managing people successfully is often far more complex. So in that se and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nse leadership is an indispensable
feature of management. Herein lies the dilemma because one of the most critical challenges that companies face is maintaining the spirit and motivation of its staff at a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi constantly high level. The other day I saw the modern version of the film "The White Feather". In the film a young officer refuses to accompany his fellow officers to wage war in the Sudan. His erstwhile ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a officers and friends offer him four white feathers, a symbol of cowardice.
He is deeply wounded by this gesture, and embarks on a journey of personal
discovery and salvation by going off to the Sudan and s dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod aving the lives of the very
same officers who sent him the white feathers. At the end of the film one of the
officers who was rescued gives a sermon in which he in effect says that empires come
and go bu cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t in the final analysis one lays down one's life not for an abstract notion like
queen and country but for the man standing next in line. In the same way one does not put oneself on the line for the company tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen , but often for a
principle or vision, or for a fellow worker next in line to yourself. And it is the latter
spirit that I referred to in the opening paragraph. If you can create that kind of
atmosphere t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel f solidarity and team spirit then you have a winning team. It is said that
you lead by example, and so managers need to lead from the front, too. And where you
have a closely knit team you also inevitably n ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust eed high levels of trust: ‘Trust capital’ as it
is otherwise known. A sense of solidarity is created well expressed in the words of the
three musketeers in the eponymous novel by Alexander Dumas, "All for y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products one and one for
all". This atmosphere of trust and solidarity is also a climate where people are unafraid of
expressing their views and ideas to others. Herein lies the key to innovation and creativity
– . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the free exchange of ideas. A kind of hothouse in which new ideas emerge. Above all, it requires a manager who is not afraid of changing the status quo. One who is not threatened by the emergence of new i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip deas and ways of thinking. It requires managers
with leadership skills; every manager should pose him or herself the fundamental question,
"Have I got what it takes?" and if not, "What must I do to get it? tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Develop Learning Potential Through Paired-Learning Great Managers Lead Differently Do You Know The 3 Top Secrets Of Explosive Sales Letters?
|